reglab/housing_qa huggingface dataset:
IA Code § 124E.5 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.5 - Medical cannabidiol board — duties.

124E.5 Medical cannabidiol board — duties.   1. a. A medical cannabidiol board is created consisting of eight practitioners representing the fields of neurology, pain management, gastroenterology, oncology, psychiatry, pediatrics, family medicine, and pharmacy, and one representative from law enforcement.   b. The practitioners shall be licensed in this state and nationally board-certified in their area of specialty and knowledgeable about the use of medical cannabidiol.   c. Applicants for membership on the board shall submit a membership application to the department and the governor shall appoint members from the applicant pool.   d. For purposes of this subsection, “representative from law enforcement” means a regularly employed member of a police force of a city or county, including a sheriff, or of the state patrol, in this state, who is responsible for the prevention and detection of crime and the enforcement of the criminal laws of this state.   2. The medical cannabidiol board shall convene at least twice per year.   3. The duties of the medical cannabidiol board shall include but not be limited to the following:   a. Accepting and reviewing petitions to add medical conditions, medical treatments, or debilitating diseases to the list of debilitating medical conditions for which the medical use of cannabidiol would be medically beneficial under this chapter.   b. Making recommendations relating to the removal or addition of debilitating medical conditions to the list of allowable debilitating medical conditions for which the medical use of cannabidiol under this chapter would be medically beneficial.   c. Working with the department regarding the requirements for the licensure of medical cannabidiol manufacturers and medical cannabidiol dispensaries, including licensure procedures.   d. Advising the department regarding the location of medical cannabidiol manufacturers and medical cannabidiol dispensaries throughout the state.   e. Making recommendations relating to the form and quantity of allowable medical uses of cannabidiol.   4. Recommendations made by the medical cannabidiol board pursuant to subsection 3, paragraphs “b” and “e”, shall be made to the board of medicine for consideration, and if approved, shall be adopted by the board of medicine by rule.   5. On or before January 1 of each year, beginning January 1, 2018, the medical cannabidiol board shall submit a report detailing the activities of the board.   6. The general assembly shall have the sole authority to revise the definition of medical cannabidiol for purposes of this chapter.  2017 Acts, ch 162, §8, 25; 2020 Acts, ch 1116, §17  Subsections 2 and 6 amended
IA Code § 124E.6 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.6 - Medical cannabidiol manufacturer licensure.

124E.6 Medical cannabidiol manufacturer licensure.   1. a. The department shall issue a request for proposals to select and license by December 1, 2017, up to two medical cannabidiol manufacturers to manufacture and to possess, cultivate, harvest, transport, package, process, or supply medical cannabidiol within this state consistent with the provisions of this chapter. The department shall license new medical cannabidiol manufacturers or relicense the existing medical cannabidiol manufacturers by December 1 of each year.   b. Information submitted during the application process shall be confidential until a medical cannabidiol manufacturer is licensed by the department unless otherwise protected from disclosure under state or federal law.   2. As a condition for licensure, a medical cannabidiol manufacturer must agree to begin supplying medical cannabidiol to medical cannabidiol dispensaries in this state no later than December 1, 2018.   3. The department shall consider the following factors in determining whether to select and license a medical cannabidiol manufacturer:   a. The technical expertise of the medical cannabidiol manufacturer regarding medical cannabidiol.   b. The qualifications of the medical cannabidiol manufacturer’s employees.   c. The long-term financial stability of the medical cannabidiol manufacturer.   d. The ability to provide appropriate security measures on the premises of the medical cannabidiol manufacturer.   e. Whether the medical cannabidiol manufacturer has demonstrated an ability to meet certain medical cannabidiol production needs for medical use regarding the range of recommended dosages for each debilitating medical condition, the range of chemical compositions of any plant of the genus cannabis that will likely be medically beneficial for each of the debilitating medical conditions, and the form of the medical cannabidiol in the manner determined by the department pursuant to rule.   f. The medical cannabidiol manufacturer’s projection of and ongoing assessment of fees on patients with debilitating medical conditions.   4. A medical cannabidiol manufacturer shall contract with a laboratory to perform spot-check testing of the medical cannabidiol produced by the medical cannabidiol manufacturer as provided in section 124E.7. The department shall require that the laboratory report testing results to the medical cannabidiol manufacturer and the department as determined by the department by rule. If a medical cannabidiol manufacturer contracts with a laboratory other than the state hygienic laboratory at the university of Iowa in Iowa City, the department shall approve the laboratory to perform testing pursuant to this chapter.   5. Each entity submitting an application for licensure as a medical cannabidiol manufacturer shall pay a nonrefundable application fee of seven thousand five hundred dollars to the department.  2017 Acts, ch 162, §9, 25; 2020 Acts, ch 1116, §18  Subsection 4 stricken and rewritten
IA Code § 124E.8 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.8 - Medical cannabidiol dispensary licensure.

124E.8 Medical cannabidiol dispensary licensure.   1. a. The department shall issue a request for proposals to select and license by April 1, 2018, up to five medical cannabidiol dispensaries to dispense medical cannabidiol within this state consistent with the provisions of this chapter. The department shall license new medical cannabidiol dispensaries or relicense the existing medical cannabidiol dispensaries by December 1 of each year.   b. Information submitted during the application process shall be confidential until a medical cannabidiol dispensary is licensed by the department unless otherwise protected from disclosure under state or federal law.   2. As a condition for licensure, a medical cannabidiol dispensary must agree to begin supplying medical cannabidiol to patients by December 1, 2018.   3. The department shall consider the following factors in determining whether to select and license a medical cannabidiol dispensary:   a. The technical expertise of the medical cannabidiol dispensary regarding medical cannabidiol.   b. The qualifications of the medical cannabidiol dispensary’s employees.   c. The long-term financial stability of the medical cannabidiol dispensary.   d. The ability to provide appropriate security measures on the premises of the medical cannabidiol dispensary.   e. The medical cannabidiol dispensary’s projection and ongoing assessment of fees for the purchase of medical cannabidiol on patients with debilitating medical conditions.   4. Each entity submitting an application for licensure as a medical cannabidiol dispensary shall pay a nonrefundable application fee of five thousand dollars to the department.  2017 Acts, ch 162, §11, 25
IA Code § 124E.10 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.10 - Fees.

124E.10 Fees.   All fees collected by the department under this chapter shall be retained by the department for operation of the medical cannabidiol registration card program and the medical cannabidiol manufacturer and medical cannabidiol dispensary licensing programs. The moneys retained by the department shall be considered repayment receipts as defined in section 8.2 and shall be used for any of the department’s duties under this chapter, including but not limited to the addition of full-time equivalent positions for program services and investigations. Notwithstanding section 8.33, moneys retained by the department pursuant to this section shall not revert to the general fund of the state but shall remain available for expenditure only for the purposes specified in this section.  2017 Acts, ch 162, §13, 25; 2018 Acts, ch 1165, §124, 126
IA Code § 124E.13 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.13 - Medical cannabidiol source.

124E.13 Medical cannabidiol source.   Medical cannabidiol provided exclusively pursuant to a written certification of a health care practitioner, if not legally available in this state or from any other bordering state, shall be obtained from an out-of-state source.  2017 Acts, ch 162, §16, 25
IA Code § 124E.14 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.14 - Out-of-state medical cannabidiol dispensaries.

124E.14 Out-of-state medical cannabidiol dispensaries.   The department of public health shall utilize a request for proposals process to select and license by December 1, 2017, up to two out-of-state medical cannabidiol dispensaries from a bordering state to sell and dispense medical cannabidiol to a patient or primary caregiver in possession of a valid medical cannabidiol registration card issued under this chapter.  2017 Acts, ch 162, §17, 25
IA Code § 124E.15 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.15 - Iowa patients and primary caregivers registering in the state of Minnesota.

124E.15 Iowa patients and primary caregivers registering in the state of Minnesota.   A patient or a primary caregiver with a valid medical cannabidiol registration card issued pursuant to this chapter may register in the state of Minnesota as a visiting qualified patient or primary caregiver and may register with one or more medical cannabis manufacturers registered under the laws of Minnesota.  2017 Acts, ch 162, §18, 25
IA Code § 124E.16 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.16 - Penalties.

124E.16 Penalties.   1. A person who knowingly or intentionally possesses or uses medical cannabidiol in violation of the requirements of this chapter is subject to the penalties provided under chapters 124 and 453B.   2. A medical cannabidiol manufacturer or a medical cannabidiol dispensary shall be assessed a civil penalty of up to one thousand dollars per violation for any violation of this chapter in addition to any other applicable penalties.  2017 Acts, ch 162, §19, 25
IA Code § 124E.17 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.17 - Use of medical cannabidiol — smoking prohibited.

124E.17 Use of medical cannabidiol — smoking prohibited.   A patient shall not consume medical cannabidiol possessed or used as authorized under this chapter by smoking medical cannabidiol.  2017 Acts, ch 162, §20, 25
IA Code § 124E.18 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.18 - Reciprocity.

124E.18 Reciprocity.   A valid medical cannabidiol registration card, or its equivalent, issued under the laws of another state that allows an out-of-state patient to possess or use medical cannabidiol in the jurisdiction of issuance shall have the same force and effect as a valid medical cannabidiol registration card issued pursuant to this chapter, except that an out-of-state patient in this state shall not obtain medical cannabidiol from a medical cannabidiol dispensary in this state.  2017 Acts, ch 162, §21, 25
IA Code § 124E.19 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.19 - Background investigations.

124E.19 Background investigations.   1. The division of criminal investigation of the department of public safety shall conduct thorough background investigations for the purposes of licensing medical cannabidiol manufacturers and medical cannabidiol dispensaries under this chapter. The results of any background investigation conducted pursuant to this section shall be presented to the department.   a. An applicant for a medical cannabidiol manufacturer license or a medical cannabidiol dispensary license and their owners, investors, and employees shall submit all required information on a form prescribed by the department of public safety.   b. The department shall charge an applicant for a medical cannabidiol manufacturer license or a medical cannabidiol dispensary license a fee determined by the department of public safety and adopted by the department by rule to defray the costs associated with background investigations conducted pursuant to the requirements of this section. The fee shall be in addition to any other fees charged by the department. The fee may be retained by the department of public safety and shall be considered repayment receipts as defined in section 8.2.   2. The department shall require an applicant for a medical cannabidiol manufacturer license or a medical cannabidiol dispensary license, their owners and investors, and applicants for employment at a medical cannabidiol manufacturer or medical cannabidiol dispensary to submit fingerprints and other required identifying information to the department on a form prescribed by the department of public safety. The department shall submit the fingerprint cards and other identifying information to the division of criminal investigation of the department of public safety for submission to the federal bureau of investigation for the purpose of conducting a national criminal history record check. The department may require employees and contractors involved in carrying out a background investigation to submit fingerprints and other identifying information for the same purpose.   3. The department may enter into a chapter 28E agreement with the department of public safety to meet the requirements of this section.   4. An applicant for a medical cannabidiol manufacturer license or a medical cannabidiol dispensary license shall submit information and fees required by this section at the time of application.   5. The results of background investigations conducted pursuant to this section shall not be considered public records under chapter 22.  2018 Acts, ch 1165, §125, 126  Referred to in §124E.7, 124E.9
IA Code § 124E.20 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.20 - Observational effectiveness study.

124E.20 Observational effectiveness study.   The department may conduct an observational effectiveness study in cooperation with patients and health care practitioners and pursuant to rules of the department in order to study the effectiveness of medical cannabidiol in the treatment of debilitating medical conditions.  2020 Acts, ch 1116, §24  NEW section
IA Code § 124E.21 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.21 - Employer regulation of marijuana use.

124E.21 Employer regulation of marijuana use.   1. Nothing in this chapter shall require an employer to permit or accommodate the use, consumption, possession, transfer, display, transportation, distribution, sale, or growing of marijuana in the workplace.   2. Nothing in this chapter shall prohibit an employer from implementing policies restricting the use of marijuana by employees for the purpose of promoting workplace health and safety.   3. Nothing in this chapter shall prohibit an employer from including in a contract with an employee a provision prohibiting the use of marijuana.   4. Nothing in this chapter shall prohibit an employer from establishing and enforcing a zero-tolerance drug policy or a drug-free workplace by use of a drug testing policy in accordance with section 730.5 or any other procedures provided by federal statutes, federal regulations, or orders issued pursuant to federal law.  2020 Acts, ch 1116, §25  NEW section
IA Code § 124E.22 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.22 - Regulation of marijuana use by government medical assistance programs, private health insurers, and other entities.

124E.22 Regulation of marijuana use by government medical assistance programs, private health insurers, and other entities.   Nothing in this chapter shall require a government medical assistance program, private health insurer, workers’ compensation carrier, or self-insured employer providing workers’ compensation benefits to reimburse a person for costs associated with the medical use of marijuana.  2020 Acts, ch 1116, §26  NEW section
IA Code § 124E.23 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.23 - Regulation of marijuana use on property.

124E.23 Regulation of marijuana use on property.   Nothing in this chapter shall require a person that owns, occupies, or controls a property to allow the use, consumption, possession, transfer, display, transportation, distribution, sale, or growing of marijuana on or in that property.  2020 Acts, ch 1116, §27  NEW section
IA Code § 124E.24 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.24 - Limitation of liability.

124E.24 Limitation of liability.   Nothing in this chapter shall create any claim, cause of action, sanction, or penalty, for discrimination or under any other theory of liability, under chapter 216 or any other provision of law, based on an act, omission, policy, or contractual provision permissible under this chapter including but not limited to refusing to hire, discharging, disciplining, discriminating, retaliating, or otherwise taking any adverse employment action against a person with respect to hiring, tenure, or any terms, conditions, or privileges of employment.  2020 Acts, ch 1116, §28  NEW section
IA Code § 124E.25 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.25 - Cannabis-derived products — exemption.

124E.25 Cannabis-derived products — exemption.   This chapter shall not apply to any cannabis-derived investigational product or cannabis-derived product approved as a prescription drug medication by the United States food and drug administration.  2020 Acts, ch 1116, §29  NEW section
IA Code § 124E.26 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 124E - MEDICAL CANNABIDIOL ACT|Section 124E.26 - Applicability.

124E.26 Applicability.   The provisions of this chapter apply notwithstanding any other provision of law to the contrary.  2020 Acts, ch 1116, §30  NEW section
IA Code § 125.1 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 125 - SUBSTANCE-RELATED DISORDERS|Section 125.1 - Declaration of policy.

125.1 Declaration of policy.   It is the policy of this state:   1. That persons with substance-related disorders be afforded the opportunity to receive quality treatment and directed into rehabilitation services which will help them resume a socially acceptable and productive role in society.   2. To encourage substance abuse education and prevention efforts and to insure that such efforts are coordinated to provide a high quality of services without unnecessary duplication.   3. To insure that substance abuse programs are being operated by individuals who are qualified in their field whether through formal education or through employment or personal experience.  [C71, 73, §123B.2; C75, 77, 79, 81, §125.1]  [A portion of subsection 1 was inadvertently omitted in the 1993 Code]  2011 Acts, ch 121, §24, 62  Referred to in §125.3, 125.7
IA Code § 125.3 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 125 - SUBSTANCE-RELATED DISORDERS|Section 125.3 - Substance abuse program established.

125.3 Substance abuse program established.   The Iowa department of public health shall develop, implement, and administer a comprehensive substance abuse program pursuant to sections 125.1 to 125.43.  [C62, 66, 71, 73, §123A.2; C75, 77, 79, 81, §125.3; 81 Acts, ch 58, §2]  86 Acts, ch 1245, §1123; 2005 Acts, ch 175, §61  Referred to in §125.7
IA Code § 125.7 (2021)
2021 Iowa Code|Title IV - PUBLIC HEALTH|Chapter 125 - SUBSTANCE-RELATED DISORDERS|Section 125.7 - Duties of the board.

125.7 Duties of the board.   The board shall:   1. Approve the comprehensive substance abuse program, developed by the department pursuant to sections 125.1 to 125.43.   2. Advise the department on policies governing the performance of the department in the discharge of any duties imposed on the department by law.   3. Advise or make recommendations to the governor and the general assembly relative to substance abuse treatment, intervention, education, and prevention programs in this state.   4. Adopt rules for subsections 1 and 6 and review other rules necessary to carry out the provisions of this chapter, subject to review in accordance with chapter 17A.   5. Investigate the work of the department relating to substance abuse, and for this purpose the board shall have access at any time to all books, papers, documents, and records of the department.   6. Consider and approve or disapprove all applications for a license and all cases involving the renewal, denial, suspension, or revocation of a license.   7. Act as the appeal board regarding funding decisions made by the department.  [C71, 73, §123B.3; C75, 77, 79, 81, §125.7]  86 Acts, ch 1245, §1126; 89 Acts, ch 243, §1; 2005 Acts, ch 175, §62  Referred to in §125.3